Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking

45 trades

Disclosure transactions for Onkure Therapeutics, Inc.
Reporting person Filed Transaction Transaction value Source Actions
Hartley Dylan Chief Scientific Officer Aug 11, 2026 4-day lag Award Aug 7, 2026 Not reported Reported range SEC Form 4 View filing
Hartley Dylan Chief Scientific Officer Aug 11, 2026 4-day lag Disposition Aug 7, 2026 Not reported Reported range SEC Form 4 View filing
Agresta Samuel Chief Medical Officer Aug 11, 2026 4-day lag Award Aug 7, 2026 Not reported Reported range SEC Form 4 View filing
Agresta Samuel Chief Medical Officer Aug 11, 2026 4-day lag Award Aug 7, 2026 Not reported Reported range SEC Form 4 View filing
Agresta Samuel Chief Medical Officer Aug 11, 2026 4-day lag Disposition Aug 7, 2026 Not reported Reported range SEC Form 4 View filing
Agresta Samuel Chief Medical Officer Aug 11, 2026 4-day lag Disposition Aug 7, 2026 Not reported Reported range SEC Form 4 View filing
Agresta Samuel Chief Medical Officer Aug 11, 2026 4-day lag Award Aug 7, 2026 $0 Filed shares x price SEC Form 4 View filing
Saccomano Nicholas A President And CEO Jun 24, 2026 2-day lag Sale Jun 22, 2026 $378.08 Filed shares x price SEC Form 4 View filing
Leverone Jason A. Chief Financial Officer Jun 24, 2026 2-day lag Sale Jun 22, 2026 $1.33K Filed shares x price SEC Form 4 View filing
Grey Michael G Director Jun 8, 2026 4-day lag Award Jun 4, 2026 $0 Filed shares x price SEC Form 4 View filing
Ratcliffe Liam Director Jun 8, 2026 4-day lag Award Jun 4, 2026 $0 Filed shares x price SEC Form 4 View filing
Phillips Andrew John Director Jun 8, 2026 4-day lag Award Jun 4, 2026 $0 Filed shares x price SEC Form 4 View filing
Jansen Valerie Malyvanh Director Jun 8, 2026 4-day lag Award Jun 4, 2026 $0 Filed shares x price SEC Form 4 View filing
Carruthers R Michael Director Jun 8, 2026 4-day lag Award Jun 4, 2026 $0 Filed shares x price SEC Form 4 View filing
Mathers Edward T Director Jun 8, 2026 4-day lag Award Jun 4, 2026 $0 Filed shares x price SEC Form 4 View filing
Hartley Dylan Chief Scientific Officer
Award
Reported value range
Not reported 137,603 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Hartley Dylan Chief Scientific Officer
Disposition
Reported value range
Not reported 137,603 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Agresta Samuel Chief Medical Officer
Award
Reported value range
Not reported 131,396 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Agresta Samuel Chief Medical Officer
Award
Reported value range
Not reported 18,588 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Agresta Samuel Chief Medical Officer
Disposition
Reported value range
Not reported 131,396 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Agresta Samuel Chief Medical Officer
Disposition
Reported value range
Not reported 18,588 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Agresta Samuel Chief Medical Officer
Award
Calculated transaction value
$0 50,000 shares @ $0
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Saccomano Nicholas A President And CEO
Sale
Calculated transaction value
$378.08 86 shares @ $4.4
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Leverone Jason A. Chief Financial Officer
Sale
Calculated transaction value
$1.33K 303 shares @ $4.4
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Grey Michael G Director
Award
Calculated transaction value
$0 7,650 shares @ $0
Traded
Jun 4, 2026
Filed
Jun 8, 2026
Ratcliffe Liam Director
Award
Calculated transaction value
$0 1,275 shares @ $0
Traded
Jun 4, 2026
Filed
Jun 8, 2026
Phillips Andrew John Director
Award
Calculated transaction value
$0 7,650 shares @ $0
Traded
Jun 4, 2026
Filed
Jun 8, 2026
Jansen Valerie Malyvanh Director
Award
Calculated transaction value
$0 7,650 shares @ $0
Traded
Jun 4, 2026
Filed
Jun 8, 2026
Carruthers R Michael Director
Award
Calculated transaction value
$0 7,650 shares @ $0
Traded
Jun 4, 2026
Filed
Jun 8, 2026
Mathers Edward T Director
Award
Calculated transaction value
$0 7,650 shares @ $0
Traded
Jun 4, 2026
Filed
Jun 8, 2026